`
`223 Fed.Appx. 999
`This case was not selected for
`publication in the Federal Reporter.
`Not for Publication in West's Federal Reporter
`See Fed. Rule of Appellate Procedure 32.1
`generally governing citation of judicial
`decisions issued on or after Jan. 1, 2007. See
`also Federal Circuit Rule 32.1 and Federal
`Circuit Local Rule 32.1. (Find CTAF Rule 32.1)
`United States Court of Appeals,
`Federal Circuit.
`
`JANSSEN PHARMACEUTICA N.V. and
`Janssen Pharmaceutica Products, L.P. (now
`known as Janssen, L.P.), Plaintiffs-Appellees,
`v.
`MYLAN PHARMACEUTICALS,
`INC., Defendant-Appellant.
`
`Nos. 2007-1021, 2007-1055.
`|
`May 11, 2007.
`|
`Rehearing and Rehearing En
`Banc Denied June 19, 2007.
`
`On Appeal from the United States District Court for the
`District of New Jersey, 03-CV-6220 and 03-CV-6185.
`
`Before GAJARSA, PROST, Circuit Judges and OTERO,
`District Judge. *
`
`*
`
`Honorable S. James Otero, District Judge, United States
`District Court for the Central District of California,
`sitting by designation.
`
`Judgment
`
`PER CURIAM.
`
`*1 This CAUSE having been heard and considered, it is
`
`ORDERED and ADJUDGED:
`
`AFFIRMED. See Fed. Cir. R. 36.
`
`All Citations
`
`223 Fed.Appx. 999, 2007 WL 1428462
`
`End of Document
`
`© 2016 Thomson Reuters. No claim to original U.S. Government Works.
`
` © 2016 Thomson Reuters. No claim to original U.S. Government Works.
`
`1
`
`NOVARTIS EXHIBIT 2086
`Par v Novartis, IPR 2016-00084
`Page 1 of 1